Abstract
In this chapter, the failure of heart rate variability and beat-to-beat blood pressure is delineated and the solution to their failings (P&S monitoring) is introduced and developed. The chapter compares graphically spectral analysis of HRV with the spectral analysis method associated with P&S monitoring. The method of spectral analysis, the Fourier transform, is developed and demonstrated and applied to both HRV and P&S monitoring. This is to demonstrate how spectral analysis quantifies the respective measurement, enabling the primary care physician to assess their patient’s ANS. The shortcomings of the Fourier transform when applied to biological, especially autonomic, signals are then elucidated and their solution in the form of wavelet transforms is introduced and developed. In conclusion, the two transform techniques are then compared graphically.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Malik M, The Task Force of the European Society of Cardiology, North American Society of Pacing and Electrophysiology. Heart rate variability, standards of measurement, physiological interpretation, and clinical use. Circulation. 1996;93:1043–65.
Malik M, Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability, standards of measurement, physiological interpretation, and clinical use. Eur Heart J. 1996;17:354–81.
Akselrod S, Gordon S, Ubel FA, Shannon DC, Berger AC, Cohen RJ. Power spectrum analysis of heart rate fluctuations: a quantitative probe of beat-to- beat cardiovascular control. Science. 1981;213:213–20.
Malik M, Camm AJ. Components of heart rate variability: what they really mean and what we really measure. Am J Cardiol. 1993;72:821–2.
Copie X, Lamaison D, Salvador M, Sadoul N, DaCosta A, Faucher L, Legal F, Le Heuzey JY, VALID Investigators. Heart rate variability before ventricular arrhythmias in patients with coronary artery disease and an implantable cardioverter defibrillator. Ann Noninvasive Electrocardiol. 2003;8(3):179–84.
Vinik AI, Murray GL. Autonomic neuropathy is treatable. US Endocrinol. 2008;2:82–4.
Low PA, editor. Clinical autonomic disorders: evaluation and management. Philadelphia: Lippincott-Raven; 1997.
Arora RR, Bulgarelli RJ, Ghosh-Dastidar S, Colombo J. Autonomic mechanisms and therapeutic implications of postural diabetic cardiovascular abnormalities. J Diabetes Sci Technol. 2008;2(4):568–71.
Vinik AI, Bloom HL, Colombo J. Differential effects of adrenergic antagonists (carvedilol vs. metoprolol) on parasympathetic and sympathetic activity: a comparison of measures. Heart International. In Print, 2014.
Bloom HL, Vinik AI, Colombo J. Differential effects of adrenergic antagonists (carvedilol vs. metoprolol) on parasympathetic and sympathetic activity: a comparison of clinical results. Heart International. In Print, 2014.
Vinik AI, Aysin B, Colombo J. Enhanced frequency domain analysis replaces older heart rate variability methods. Fourth annual diabetes technology meeting, Philadelphia, 28–30 Oct 2004.
Vinik AI, Aysin B, Colombo J. Resting enhanced frequency domain analysis improves heart rate variability sensitivity in early and late diabetics. Diabetes technology conference, San Francisco, 10–12 Nov 2005.
Aysin B, Aysin E. Effect of respiration in heart rate variability (HRV) analysis. Conf Proc IEEEE Med Biol Soc. 2006;1:1776–9. PubMed: 17946068.
Aysin B, Aysin E, Colombo J. Comparison of HRV analysis methods during orthostatic challenge: HRV with respiration or without? IEEE engineering in medicine and biology conference, Lyons, 2007.
Vinik AI, Aysin B, Colombo J. Enhanced frequency domain analysis identifies early autonomic dysfunction that may lead to elevated blood pressure in diabetics. Diabetes technology conference, San Francisco, 10–12 Nov 2005.
Arora RR, Aysin E, Aysin B, Colombo J. Therapeutic implications of sympathetic stimulus in orthostatic patients: measured by spectral domain analysis. AHA scientific sessions, Orlando, 4–7 Nov 2007.
Vinik AI, Aysin B, Colombo J. Differentiation of autonomic dysfunction by enhanced frequency domain analysis reveals additional stages in the progression of autonomic decline in diabetics. Diabetes technology conference, San Francisco, 10–12 Nov 2005.
Colombo J, Jacot J, Aysin E, Aysin B, Iffrig K, Vinik AI. Symptoms of orthostasis may be due to sympathetic/parasympathetic autonomic imbalance and can be evaluated by hrv with respiratory analysis with appropriate pathogenesis oriented therapeutic choices. International symposium on diabetes neuropathy, 7th annual congress, Cape Town, 29 Nov–2 Dec 2007.
Arora RR, Shoemaker WC, Iffrig K, Colombo J. Spectral analysis of respiratory activity provides a second autonomic measure associated with spectral analysis of heart rate variability. American Autonomic Society’s 17th international symposium on the autonomic nervous system, Rio Grande, Nov 2006.
Ali MA, Waheed A, Jurivich DA, Colombo J, Singer DH. Short-term time domain HRV measures: comparisons with 24-hr Holter monitoring. Geriatric medicine society meeting, Chicago, May 2006.
Arora RR, Colombo J. Orthostatic syndromes are associated by sympathetic withdrawal as demonstrated by non-invasive autonomic monitoring. American Autonomic Society, 17th international symposium, Kauai, 29 Oct–1 Nov 2008.
Vinik AI, Aysin B, Colombo J. Dynamic enhanced frequency domain analysis indicates a significant decline in autonomic function before age 50. Presented at the diabetes technology conference, San Francisco. 10–12 Nov 2005.
Barnsley M. Fractals everywhere. San Diego: Academic; 1988.
Ewing DJ. Cardiovascular reflexes and autonomic neuropathy. Clin Sci Mol Med. 1978;55(4):321–7.
Ewing DJ, Clarke BF. Diagnosis and management of diabetic autonomic neuropathy. Br Med J. 1982;285:916–8.
Ewing DJ, Martyn CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care. 1985;8:491–8.
Vinik AI, Maser RE, Nakave AA. Diabetic cardiovascular autonomic nerve dysfunction. US Endocr Dis. 2007;2:2–9.
Vinik A, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation. 2007;115:387–97.
Carney RM, Blumenthal JA, Freedland KE, Stein PK, Howells WB, Berkman LF, Watkins LL, Czajkowski SM, Hayano J, Domitrovich PP, Jaffe AS. Low heart rate variability and the effect of depression on post–myocardial infarction mortality. Arch Intern Med. 2005;165:1486–91.
Litchman JH, Bigger Jr JT, Blumenthal JA, et al. Depression and coronary heart disease recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation. 2008;118:1768–75.
Silver MA. Depression and heart failure: an overview of what we know and don’t know. Cleve Clin J Med. 2010;77 Suppl 3:S7–11.
Barefoot JC, Helms MJ, Mark DB, Blumenthal JA, Califf RM, Haney TL, O’Connor CM, Siegler IC, Williams RB. Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol. 1996;78:613–7.
Davidson KW, Rieckmann N, Lesperance F. Psychological theories of depression: potential application for the prevention of acute coronary syndrome recurrence. Psychosom Med. 2004;66:165–73.
Lett HS, Blumenthal JA, Babyak MA, Sherwood A, Strauman T, Robins C, Newman MF. Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med. 2004;66:305–15.
Frasure-Smith N, Lesperance F, Gravel G, Masson A, Juneau M, Talajic M, Bourassa MG. Social support, depression, and mortality during the first year after myocardial infarction. Circulation. 2000;101:1919–24.
Lespérance F, Frasure-Smith N, Juneau M, Théroux P. Depression and 1-year prognosis in unstable angina. Arch Intern Med. 2000;160(9):1354–60.
Joynt KE, Whellan DJ, O’Connor CM. Depression and cardiovascular disease: mechanisms of interaction. Biol Psychiatry. 2003;54:248–61.
Boulton AJM, Vinik AI, Arrezzo JC, Bril V, Feldman EI, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005;28(4):956–62.
American Diabetes Association. Standards of medical care in diabetes – 2008. Diabetes Care. 2008;31 Suppl 1:S12–54.
American Diabetes Association. Standards of medical care in diabetes – 2013. Diabetes Care. 2013;36 Suppl 1:S11–66.
Handelsman Y, AACE task force for developing a diabetes comprehensive care plan. American Association of Clinical Endocrinologists medical guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan. Endocr Pract. 2011;17 Suppl 2:1–53.
Low PA, Engstrom JW. Disorders of the autonomic nervous system. In: Harrison’s principles of internal medicine. 16th ed. New York: McGraw-Hill; 2003.
Curtis BM, O’Keefe JH. Autonomic tone as a cardiovascular risk factor: the dangers of chronic fight or flight. Mayo Clin Proc. 2002;77:45–54.
Umetani K, Singer DH, McCraty R, Atkinson M. Twenty-four hour time domain heart rate variability and heart rate: relations to age and gender over nine decades. J Am Coll Cardiol. 1998;31(3):593–601.
Low PA and the Therapeutics and Technology Assessment Subcommittee Assessment. Clinical autonomic testing report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology. 1996;46:873–80.
Nanavati SH, Bulgarelli RJ, Vazquez-Tanus J, Ghosh-Dastidar S, Colombo J, Arora RR. Altered autonomic activity with atrial fibrillation as demonstrated by non-invasive autonomic monitoring. US Cardiol. 2010;7(1):47–50.
Vinik AI, Freeman R, Erbas T. Diabetic autonomic neuropathy. Semin Neurol. 2003;23:365–72.
DePace NL, Mears JP; Yayac M, Colombo J. Cardiac autonomic testing and diagnosing heart disease. A clinical perspective. In Print, 2014.
DePace NL, Mears JP; Yayac M, Colombo J. Cardiac autonomic testing and treating heart disease. A clinical perspective. In Print, 2014.
Bullinga JR, Alharethi R, Schram MS, Bristow MR, Gilbert EM. Changes in heart rate variability are correlated to hemodynamic improvement with chronic CARVEDILOL therapy in heart failure. J Card Fail. 2005;11(9):693–9.
Fatoni C, Raffa S, Regoli F, Giraldi F, La Rovere MT, Prentice J, Pastori F, Fratini S, Salerno-Uriarte JA, Klein HU, Auricchio A. Cardiac resynchronization therapy improves heart rate profile and heart rate variability of patients with moderate to severe heart failure. J Am Coll Cardiol. 2005;46(10):1875–82.
Fathizadeh P, Shoemaker WC, Woo CCJ, Colombo J. Autonomic activity in trauma patients based on variability of heart rate and respiratory rate. Crit Care Med. 2004;32(5):1300–5.
Chen JY, Fung JW, Yu CM. The mechanisms of atrial fibrillation. J Cardiovasc Electrophysiol. 2006;17 Suppl 3:S2–7.
Alter P, Grimm W, Vollrath A, Czerny F, Maisch B. Heart rate variability in patients with cardiac hypertrophy–relation to left ventricular mass and etiology. Am Heart J. 2006;151(4):829–36.
Debono M, Cachia E. The impact of cardiovascular autonomic neuropathy in diabetes: is it associated with left ventricular dysfunction? Auton Neurosci. 2007;132(1–2):1–7.
Just H. Peripheral adaptations in congestive heart failure: a review. Am J Med. 1991;90:23S–6.
Nakamura K, Matsumura K, Kobayashi S, Kaneko T. Sympathetic premotor neurons mediating thermoregulatory functions. Neurosci Res. 2005;51(1):1–8.
Manfrini O, Morgagni G, Pizzi C, Fontana F, Bugiardini R. Changes in autonomic nervous system activity: spontaneous versus balloon-induced myocardial ischaemia. Eur Heart J. 2004;25(17):1502–8.
Clarke B, Ewing D, Campbell I. Diabetic autonomic neuropathy. Diabetologia. 1979;17:195–212.
Oppenheim AV, Willsky AS, Young IT. Signals and systems. Englewood Cliffs: Prentice-Hall; 1983.
Peles E, Goldstein DS, Akselrod S, Nitzan H, Azaria M, Almog S, Dolphin D, Halkin H, Modan M. Interrelationships among measures of autonomic activity and cardiovascular risk factors during orthostasis and the oral glucose tolerance test. Clin Auton Res. 1995;5(5):271–8.
Kingwell BA, Thompson JM, Kaye DM, McPherson GA, Jennings GL, Esler MD. Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure. Circulation. 1994;90:234–40.
Tygesen H, Rundqvist B, Waagstein F, Wennerblom B. Heart rate variability measurement correlates with cardiac norepinephrine spillover in congestive heart failure. Am J Cardiol. 2001;87:1308–11.
Akselrod S. Components of heart rate variability: basic studies. In: Malik M, editor. Heart rate variability. Armonk: Futura Publishing Co; 1995. p. 147–63.
Akselrod S, Gordon D, Madwed JB, Snidman NC, Shannon DC, Cohen RJ. Hemodynamic regulation: investigation by spectra analysis. Am J Physiol. 1985;249:H867–75.
Akselrod S, Eliash S, Oz O, Cohen S. Hemodynamic regulation in SHR: investigation by spectral analysis. Am J Physiol. 1987;253:H176–83.
Olivera MM, Santos-Bento M, Xavier R, Rocha I, Ducla-Soares J-L, Ferreira R, Silva-Carvalho L. Wavelet analysis for the evaluation of cardiovascular autonomic nervous response to postural change in healthy subjects in relation to age. Second joint meeting of the European Federation of Autonomic Societies and the American Autonomic Society, Vienna, Austria. Clinical Autonom Res. 2007;17(5):301.
Olivera MM, Feliciano J, da-Silva N, Alves S, Xavier R, Rocha I, Silva-Carvalho L, Ferreira R. Wavelet Analysis for the evaluation of autonomic nervous system during orthostatic stress in paroxysmal atrial fibrillation. Second Joint Meeting of the European Federation of Autonomic Societies and the American Autonomic Society, Vienna, Austria. Clinical Autonom Res. 2007;17(5):301.
Olivera MM, Da-Silva N, Timoteo AT, Feliciano J, Silva S, Xavier R, Rocha I, Silva-Carvalho L, Ferreira R. Alterations in autonomic response during head-up tilt testing in paroxysmal atrial fibrillation patients: a wavelet analysis. Rev Port Cardiol. 2009;28(3):243–57.
Toledo E, Akselrod S, Pinhas I, Aravot D. Does synchronization reflect a true interaction in the cardiorespiratory system? Med Eng Phys. 2002;24(1):45–52.
Pyetan E, Akselrod S. Do the high-frequency indexes of HRV provide a faithful assessment of cardiac vagal tone? A critical theoretical evaluation. IEEE Trans Biomed Eng. 2003;50(6):777–83.
Merri M, Farden DC, Mottley JG, Titlebaum EL. Sampling frequency of electrocardiograms for spectral analysis of the heart rate variability. IEEE Trans Biomed Eng. 1990;37:99–106.
Benedetto JJ, Frazier MW, editors. Wavelets: mathematics and applications. Boca Raton: CRC Press; 1994.
Keissar K, Davrath LR, Akselrod S. Coherence analysis between respiration and heart rate variability using continuous wavelet transform. Philos Trans A Math Phys Eng Sci. 2009;367(1892):1393–406.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Colombo, J., Arora, R., DePace, N.L., Vinik, A.I. (2015). Drawbacks of Heart Rate Variability Analysis and Application of Parasympathetic and Sympathetic Monitoring. In: Clinical Autonomic Dysfunction. Springer, Cham. https://doi.org/10.1007/978-3-319-07371-2_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-07371-2_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-07370-5
Online ISBN: 978-3-319-07371-2
eBook Packages: MedicineMedicine (R0)